肺癌化疗耐药机制的研究进展

被引:6
作者
杨朝阳
陈公琰
机构
[1] 哈尔滨医科大学附属肿瘤医院内一科
关键词
肺癌化疗; 烷基转移; DNA; 耐药性; 抗药性; 小细胞肺癌; 肿瘤细胞; NSCLC; 肺癌患者; Topo; 耐药机制; MDR; 化疗药物;
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
摘要
引用
收藏
页码:465 / 469
页数:5
相关论文
共 8 条
[1]   肺癌中金属硫蛋白的表达及其与细胞增殖、凋亡的关系 [J].
王彦 ;
吴焕明 .
中国组织化学与细胞化学杂志, 2003, (04) :393-398
[2]   Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines [J].
Heim, MM ;
Eberhardt, W ;
Seeber, S ;
Müller, MR .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2000, 126 (04) :198-204
[3]  
Altered ERCC1 expression correlates with response to cisplatin (DDP) + gemcitabine (GEM) in non-small-cell lung cancer (NSCLC) patients (pts). Rosell R,Danenberg K,Gandara D, et al. ProcAm Soc Clin Oncol . 2001
[4]  
PTEN mutations are common in sporadic microsatellite stable colorectal cancer. Nassif NT, Lobo GP, Wu X, et al. Oncegene . 2004
[5]  
MRP3, an organic anion transporter able to transport anti-cancer drugs. Kool M, van der Linden M, de Haas M, et al. Proceedings of the National Academy of Sciences of the United States of America . 1999
[6]  
Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. Young LC, Campling BG, Voskoglou-Nomikos T, et al. Clinical Cancer Research . 1999
[7]  
The utility of p53 immu-nostaining of tranosbronchial biopsy specimens in advanced non-small-cell lung cancer. Kawasaki,Nakanishi Y,Kuwano K,et al. Clinical Cancer Research . 1997
[8]  
Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs. Berger W, Elbling L, Micksche M. International Journal of Cancer . 2000